Effects of Virtual Discrete Trial Training on Children With Autism Spectrum Disorder

NCT ID: NCT06522490

Last Updated: 2024-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-02

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder categorized by deficits in social communication and the occurrence of restricted interests and repetitive behaviors. The cautionary needs of children with ASD are significant, it affects parents and siblings as well and requires substantial social support. If adequate intervention is not provided to children with ASD on time, then they may face many difficulties for example in academic work. They face social isolation and may develop additional challenging behaviors. Applied behavior analysis (ABA) is one of the most commonly used supported treatments for autism spectrum disorder. Discrete Trial Training (DTT) is one of the most structured Applied Behavior Analysis (ABA) types. DTT is the best standardized therapy for ASD. The ABA explores human interactions with their environment over time and develops interventional strategies to diminish the decline in the troublesomeness of social behavior among individuals with ASD. DTT through video training Program will be an effective in improving the communication skills of children with ASD. The video training program offers excellent accessibility and is inexpensive because it can be administered remotely and at home as well. It also reduces the resource barrios.

A randomized controlled study was conducted on children aged between 3-10 years diagnosed with ASD at PSRD hospital having Different severity levels. DTT was provided through a video training program using digital technology with informed consent from their caregivers/parents. The sample size was 10. Both groups contain 5 participants. The treatment group will be trained on DTT through the video training program. Sessions were conducted thrice a week for 45 minutes. The duration of the experiment was 12 weeks. The control group did not intervene with the video training program during the experiment. Pre \& Post language assessment was done through British Picture Vocabulary Scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Video Training was used for the experimental group

Group Type EXPERIMENTAL

Virtual discrete trial training

Intervention Type OTHER

VDT was given to Experimental group.

Controlled group

Face to face therapy was used for the control group

Group Type ACTIVE_COMPARATOR

Virtual discrete trial training

Intervention Type OTHER

VDT was given to Experimental group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual discrete trial training

VDT was given to Experimental group.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Face to face therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age range between 3-10 years.
* Clinically diagnosed children from Psychologists were taken for study who had 2-3 words in vocabulary or no vocabulary at all.
* Each group received 3 weekly sessions for 45 minutes for 12 weeks.
* Video training was given through animated videos.

Exclusion Criteria

* Children with any comorbidities e.g. Intellectual Disability, Cerebral Palsy, Attention Deficit Hyperactive Disorder, Down's Syndrome and Hearing Impaired children will exclude from this study.
* Children diagnosed with severe autism.
Minimum Eligible Age

3 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shahzadi Arshad, MS SLP

Role: PRINCIPAL_INVESTIGATOR

Pakistan Society for Rehabilitation of differently abled

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pakistan society for rehabilitation of differently abled

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RiphahIU-123 Shahzadi Arshad

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.